GE Healthcare, Heads Up: Thermogenesis Would Make A Great Buy

by Original Signal - Transmitting Finance at Original Signal - Transmitting Finance

Related Stocks: GE, KOOL H.S. Ayoub submits: Thermogenesis (KOOL) continues to be an enigma, a company constantly on the verge of great things but often falling short. The cord blood stem cell processing company's third quarter numbers were nothing new; great increase in revenues, over 60%, but an increase in total loss. Complete Story »

You might be interested in these entries too:

Thermogenesis Trips on Manufacturing Capacity Bump

H.S. Ayoub submits: Thermogenesis Corp (KOOL), a developer of cord blood collection and processing units, released subpar fiscal second quarter results on Friday.While earnings increased by 19%,...

Thermogenesis Answers FDA about CryoSeal System

H.S. Ayoub submits: On Tuesday, Thermogenesis Corp (KOOL) announced that it had submitted the necessary paperwork answering certain questions the FDA had regarding its pre-market approval application...